Lung Cancer - Small Cell


Edward S. Kim, M.D., FACP, examines the emergence of immunotherapy as a treatment option for small cell lung cancer.
View more at http://curetoday.com/
CURE: Combining science and humanity to make cancer understandable.


Link to Full Transcript: https://bit.ly/3qivWm7
Dr. David Carbone discusses the differences between small cell and non-small cell lung cancer. Dr. Carbone then describes the subtypes of non-small cell lung cancer and which types are most common.
Dr. David Carbone is a medical oncologist and professor of internal medicine at The Ohio State University. Dr. Carbone is also co-leader of the Translational Therapeutics Program at the OSUCCC – James, where serves as director of the Thoracic Oncology Center. Learn more about Dr. Carbone, here: https://cancer.osu.edu/find-a-....doctor/search-physic
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: powerfulpatients.org/connect


In the continuation of a case-based discussion, panelists describe the appropriateness of maintenance therapy for a functional 77 year-old man with squamous cell non-small cell lung cancer. The patient was initially treated with 4 to 6 cycles of doublet therapy.
For more from this discussion, visit http://www.onclive.com/peer-ex....change/nsclc-therapi


Visit http://www.ecancer.org for more
Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)